Solid-state properties of 1,2-epoxy-3-(2-cyanophenoxy)propane, a conglomerate-forming chiral drug precursor

Mendeleev Communications

Volumn 16, Issue 5, 2006, Pages 245-247

  Bredikhin, Alexander A ^a   Bredikhina, Zemfira A ^a   Zakharychev, Dmitry V ^a   Akhatova, Flyura S ^a   Krivolapov, Dmitry B ^a   Litvinov, Igor A ^a  

^a A E ARBUZOV INSTITUTE OF ORGANIC AND PHYSICAL CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33751058684     PISSN: 09599436     EISSN: 1364551X     Source Type: Journal    
DOI: 10.1070/MC2006v016n05ABEH002388     Document Type: Article

References (23)

1. th edn., ed. S. Budavari, Merck and Co., Inc., Whitehouse Station, 1996, 1514 (bunitrolol) and 3641 (epanolol).
2. R. Mehvar and D. R. Brocks, J. Pharm. Pharm. Sci., 2001, 4, 185.
3. (a) J. A. Nathanson, J. Pharmacol. Exp. Ther., 1988, 245, 94;
4. (b) S. Narimatsu, T. Mizukami, Y. Huang, Y. Masubuchi and T. Suzuki, J. Pharm. Pharmacol., 1996, 48, 1185.
5. A. A. Bredikhin, E. I. Strunskaya, D. V. Zakharychev, D. B. Krivolapov, I. A. Litvinov and Z. A. Bredikhina, Tetrahedron: Asymmetry, 2005, 16, 3361.
6. K. Kopka, S. Wagner, B. Riemann, M. P. Law, C. Puke, S. K. Luthra, V. W. Pike, T. Wichter, W. Schmitz, O. Schober and M. Schäfers, Bioorg. Med. Chem., 2003, 11, 3513.
7. M. Nicola, A. Depaoli and M. Inglesi, Gazz. Chim. Ital., 1990, 120, 393.
8. (a) D. E. McClure, B. H. Ariston and J. J. Baldwin, J. Am. Chem. Soc., 1979, 101, 3666;
9. (b) J. J. Baldwin, D. E. McClure, D. M. Gross and M. Williams, J. Med. Chem., 1982, 25, 931.
10. I. A. Sayyed, V. V. Thakur, M. D. Nikalje, G. K. Dewkar, S. P. Kotkar and A. Sudalai, Tetrahedron, 2005, 61, 2831.
11. th edn., ed. S. Budavari, Merck and Co., Inc., Whitehouse Station, 1996, 1055 (befunolol), 5488 (levobunolol), 6347 (moprolol), 7209 (penbutolol), 7882 (practolol), 7917 (prenalterol) and 9585 (timolol);
12. (b) Sigma Biochemicals and Reagents for Life Science Research, 2004-2005; pp. 224 (atenolol), 1629 (pindolol) and 1696 (propranolol).
13. J. Jaques, A. Collet and S. H. Wilen, Enantiomers, Racemates, and Resolutions, Krieger Publishing Co., Malabar, FL, 1994, pp. 32-57.
14. Z. J. Li, M. T. Zell, E. J. Munson and D. J. W. Grant, J. Pharm. Sci., 1999, 88, 337.
15. H. E. Gallis, F. Bougrioua, H. A. J. Oonk, P. J. van Ekeren and J. C. van Miltenburg, Thermochim. Acta, 1996, 274, 23.
16. (a) S. Houllemare-Druot and G. Coquerel, J. Chem. Soc., Perkin Trans. 2, 1998, 2211;
17. (b) F. Dufour, G. Perez and G. Coquerel, Bull. Chem. Soc. Jpn., 2004, 77, 79.
18. V. Yu. Torbeev, K. A. Lyssenko, O. N. Kharybin, M. Yu. Antipin and R. G. Kostyanovsky, J. Phys. Chem. B, 2003, 107, 13523.
19. A. Altomare, G. Cascarano, C. Giacovazzo and D. Viterbo, Acta Crystallogr., Sect. A., 1991, 47, 744.
20. G. M. Sheldrick, SHELXL97, University of Göttingen, 1997.
21. L. J. Farrugia, J. Appl. Crystallogr., 1999, 32, 837.
22. L. H. Straver, A. J. Schierbeek, MolEN Structure Determination System, Nonius B.V., 1994.
23. A. L. Spek, Acta Crystallogr., Sect. A, 1990, 46, 34.